— Know what they know.
Not Investment Advice

249420.KS KSC

Ildong Pharmaceutical Co., Ltd.
1W: +4.8% 1M: +0.1% 3M: -13.8% YTD: -60.0% 1Y: -30.6% 3Y: -10.1% 5Y: -9.9%
₩14,510.00 ($10.81)
-60.00 (-0.41%)
 
Weekly Expected Move ±6.4%
₩12643 ₩13577 ₩14510 ₩15443 ₩16377
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · ₩457.2B mcap · 21M float · 1.22% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩457.2B ($340.5M)
52W Range11250-45050
Volume136,276
Avg Volume251,593
Beta0.84
Dividend₩200.00
Analyst Ratings
No analyst coverage
Company Info
CEOYun Paul Woongsup
Employees1,104
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2016-08-31
Websiteildong.com
2, Baumoe-ro 27-gil
Seoul, SL 137-130
KR
82 2 526 3114
About Ildong Pharmaceutical Co., Ltd.

Ildong Pharmaceutical Co., Ltd., established in 1941 and headquartered in Seoul, South Korea, is a company dedicated to the development, production, and distribution of a wide array of pharmaceutical products. Its extensive portfolio includes various medications such as anti-diarrheal agents, antibiotics, antifungals, antivirals, antihistamines, anticancer drugs, NSAIDs, and pain relievers, along with essential vitamins, minerals, and nutritional supplements. The company also produces treatments for numerous bodily systems, including cardiovascular, central nervous, dental, endocrine, gastrointestinal, respiratory, topical, and urogenital health, as well as those for blood circulation. Beyond pharmaceuticals, Ildong offers raw material drugs, health foods, cosmetics, and specialized medical devices, such as scar treatment products. Their range also extends to unique treatments for conditions like osteoarthritis, wound care, artificial tears, and feminine hygiene products. In addition to its product offerings, the company manages licenses and provides contract manufacturing services. With a global reach, Ildong Pharmaceutical exports its products to approximately 20 countries. Furthermore, the company has entered into a strategic collaboration with Evotec SE, leveraging Evotec's INDiGO platform to accelerate the development of its proprietary projects.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms